newest glp-1 drug New study shows popular weight loss may slow biological aging What to know about how
Description
The study found that peripheral endothelial dysfunction independently correlated with future cardiovascular events, thus providing additional clinical significance for risk stratification in HFpEF patients
Just get the protein in
Staiger D, Stock JH
Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist
One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice
